Quantcast

Rockville-based EntreMed shows loss in fourth quarter (access required)

Posted: 12:43 pm Thu, March 21, 2013
By Daily Record Staff

EntreMed Inc., of Rockville, a clinical-stage pharmaceutical company developing drugs for the treatment of cancer, reported a fourth-quarter net loss of $360, 4303, or 2 cents per diluted share, versus net income of 1 million, or 6 cents per diluted share, for the prior-year period.

Comments

Comments are closed.

Copyright © 2012, Maryland Daily Record 11 E. Saratoga Street, Baltimore, MD, 21202 · Tel: 443-524-8100